Proteins located on Plasmodium falciparum merozoites, the invasive form of the parasite's asexual blood stage, are of considerable interest in vaccine research. Merozoite surface protein 7 (MSP7) forms a complex with MSP1 and is encoded by a member of a multigene family located on chromosome 13. The family codes for MSP7 and five MSP7-related proteins (MSRPs). In the present study, we have investigated the expression and the effect of msrp gene deletion at the asexual blood stage. In addition to msp7, msrp2, msrp3, and msrp5 are transcribed, and mRNA was easily detected by hybridization analysis, whereas mRNA for msrp1 and msrp4 could be detected only by reverse transcription (RT)-PCR. Notwithstanding evidence of transcription, antibodies to recombinant MSRPs failed to detect specific proteins, except for antibodies to MSRP2. Sequential proteolytic cleavages of MSRP2 resulted in 28-and 25-kDa forms. However, MSRP2 was absent from merozoites; the 25-kDa MSRP2 protein (MSRP2 25 ) was soluble and secreted upon merozoite egress. The msrp genes were deleted by targeted disruption in the 3D7 line, leading to ablation of full-length transcripts. MSRP deletion mutants had no detectable phenotype, with growth and invasion characteristics comparable to those of the parental parasite; only the deletion of MSP7 led to a detectable growth phenotype. Thus, within this family some of the genes are transcribed at a significant level in asexual blood stages, but the corresponding proteins may or may not be detectable. Interactions of the expressed proteins with the merozoite also differ. These results highlight the potential for unexpected differences of protein expression levels within gene families.The human malaria parasite Plasmodium falciparum continues to be a major public health challenge mainly in developing countries, claiming more than one million lives annually. The invasion of erythrocytes and the subsequent cycles of growth, replication, and rupture of infected cells are responsible for the primary pathological consequences, such as rapid hemolysis consequent upon merozoite release and metabolic acidosis (17). Therefore, the blood stage of the parasite life cycle is a primary target for interventions to combat malaria disease. Merozoite surface proteins (MSPs) are considered to be among the best candidate antigens for inclusion in an antimalarial vaccine (15, 39). Their surface location implicates these proteins in the initial attachment and invasion of red cells by merozoites and offers good accessibility to host antibodies. Several MSPs are being assessed as vaccine candidates (10,12,17,43).Merozoite surface protein 1 (MSP1) is located on the developing merozoite surface in association with at least two other proteins-MSP6 and MSP7. Upon invasion of erythrocytes in culture, this protein complex is shed into the supernatant by proteolytic cleavage (3, 4). The complex is comprised of 4 polypeptides generated by sequential proteolytic cleavage of the MSP1 precursor and one polypeptide each from MSP6 (36-kDa protein [...